Table 1 Baseline characteristics of model and validation cohorts; correct prediction of SASE (percentage) in the validation cohort
Model cohort (n = 10,904) | Validation cohort (n = 5423) | Correctly predicted by SASE (%) | |
|---|---|---|---|
Basic data female/male | |||
Percent (%) | 52.3/47.7 | 49.0/51.0 | |
Mean age (± standard deviation) | 70.2 (± 17.4)/68.3 (± 14.9) | 70.6 (± 17.1)/69.0 (± 14.6) | |
Comorbidities overall (%) | |||
Cardiac insufficiency | 11.6 | 12.1 | |
Coronary heart disease | 10.8 | 12.5 | |
Respiratory failure | 3.7 | 2.8 | |
Cirrhosis | 2.1 | 1.8 | |
Success overall (%) | |||
Cannulation of desired duct | 92.5 | 93.3 | 93.2 |
Achievement of therapeutic target | 86.9 | 86.8 | 87.0 |
AE overall (%) | |||
Post ERCP pancreatitis | 3.5 | 4.7 | 95.3 |
Bleeding | 3.7 | 4.8 | 95.2 |
At least one AE | 9.5 | 11.2 | 88.8 |